Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Fragile X population carrier screening.

Metcalfe SA, Archibald AD, Couns G.

Genet Med. 2012 Mar;14(3):350; author reply 351. doi: 10.1038/gim.2011.79. No abstract available.

PMID:
22391783
2.

Expanded carrier screening and the law of unintended consequences: from cystic fibrosis to fragile X.

Grody WW.

Genet Med. 2011 Dec;13(12):996-7. doi: 10.1097/GIM.0b013e31823c49a2. No abstract available.

PMID:
22134443
3.

Cystic fibrosis and fragile X syndrome: the arguments for antenatal screening.

Murray J, Cuckle H.

Comb Chem High Throughput Screen. 2001 May;4(3):265-72. Review.

PMID:
11375741
4.

"It's something I need to consider": decisions about carrier screening for fragile X syndrome in a population of non-pregnant women.

Archibald AD, Jaques AM, Wake S, Collins VR, Cohen J, Metcalfe SA.

Am J Med Genet A. 2009 Dec;149A(12):2731-8. doi: 10.1002/ajmg.a.33122.

PMID:
19938084
5.

Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues.

Bailey DB Jr, Skinner D, Davis AM, Whitmarsh I, Powell C.

Pediatrics. 2008 Mar;121(3):e693-704. doi: 10.1542/peds.2007-0820. Review.

PMID:
18310190
6.

Cystic fibrosis, genetics, and DNA technology.

Nugent CE.

Curr Opin Obstet Gynecol. 1991 Apr;3(2):235-41. Review.

PMID:
1912355
7.

"It's about having the choice": stakeholder perceptions of population-based genetic carrier screening for fragile X syndrome.

Archibald AD, Hickerton CL, Jaques AM, Wake S, Cohen J, Metcalfe SA.

Am J Med Genet A. 2013 Jan;161A(1):48-58. doi: 10.1002/ajmg.a.35674. Epub 2012 Dec 13.

PMID:
23239566
8.

Pediatricians' attitudes toward expanding newborn screening.

Acharya K, Ackerman PD, Ross LF.

Pediatrics. 2005 Oct;116(4):e476-84.

PMID:
16199673
9.

Prenatal genetic testing.

Dolan SM.

Pediatr Ann. 2009 Aug;38(8):426-30. doi: 10.3928/00904481-20090723-05. No abstract available.

PMID:
19711880
10.

Population-based carrier screening and prenatal diagnosis.

Strom CM.

MLO Med Lab Obs. 2004 Aug;36(8):12-7; quiz 20-1. No abstract available.

PMID:
15366363
11.

Attitudes of genetic counselors towards expanding newborn screening and offering predictive genetic testing to children.

Hiraki S, Ormond KE, Kim K, Ross LF.

Am J Med Genet A. 2006 Nov 1;140(21):2312-9.

PMID:
17036312
12.

Genetic screening and counseling.

Norton ME.

Curr Opin Obstet Gynecol. 2008 Apr;20(2):157-63. doi: 10.1097/GCO.0b013e3282f73230. Review.

PMID:
18388816
13.

Screening for fragile X syndrome.

Murray J, Cuckle H, Taylor G, Hewison J.

Health Technol Assess. 1997;1(4):i-iv, 1-71. Review.

14.

Update on population-based preconception and prenatal cystic fibrosis carrier screening.

Nolen AA, Rhoades ED.

J Okla State Med Assoc. 2003 Oct;96(10):482-4. Review.

PMID:
14619603
16.

Applying CFTR molecular genetics to facilitate the diagnosis of cystic fibrosis through screening.

Bobadilla JL, Farrell MH, Farrell PM.

Adv Pediatr. 2002;49:131-90. Review. No abstract available.

PMID:
12214770
17.

Carrier diagnosis of the fragile X syndrome--a challenge in antenatal clinics.

Ryynänen M, Kirkinen P, Mannermaa A, Saarikoski S.

Am J Obstet Gynecol. 1995 Apr;172(4 Pt 1):1236-9.

PMID:
7726262
18.

[Screening for carriers of the fragile X syndrome; ethical exploration].

de Jong A, de Wert G.

Ned Tijdschr Geneeskd. 2002 Mar 30;146(13):611-5. Dutch.

PMID:
11957380
19.

Cost-effectiveness analysis of prenatal population-based fragile X carrier screening.

Musci TJ, Caughey AB.

Am J Obstet Gynecol. 2005 Jun;192(6):1905-12; discussion 1912-5.

PMID:
15970847
20.

Fragile X syndrome.

Donnenfeld AE.

Indian J Pediatr. 1998 Jul-Aug;65(4):513-8. Review.

PMID:
10773898

Supplemental Content

Support Center